Showing 1,121 - 1,140 results of 100,434 for search '(( 5 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.73s Refine Results
  1. 1121
  2. 1122
  3. 1123
  4. 1124
  5. 1125
  6. 1126
  7. 1127

    Loss of Rumi leads to intracellular accumulation and decreased IRS levels of Eys in a temperature dependent manner at the mid-pupal stage. by Amanda R. Haltom (664189)

    Published 2014
    “…The scale bar in A applies to A–G′ and is 5 µm. (A,A′) A wild-type ommatidium at 55% PD raised at 18°C. …”
  8. 1128
  9. 1129
  10. 1130
  11. 1131
  12. 1132

    Cluster analysis of the spatial distribution of heterochromatin and euchromatin after irradiation with 0.5 Gy and 3.5 Gy. by Yang Zhang (30734)

    Published 2015
    “…We observe a decrease in the ratio of the clustered points 6 h after irradiation for both doses. 24 h after irradiation these changes are reverted. …”
  13. 1133
  14. 1134
  15. 1135
  16. 1136
  17. 1137
  18. 1138

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  19. 1139

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  20. 1140